Skip to main content

HIV | GileadPro

HIV Events & Congresses

19th European AIDS Conference

October 18-21, 2023
Warsaw, Poland
HIV-Medication-Access

HIV Medication Access

For more than a decade, Gilead Sciences has been a leader in the development of antiretroviral therapies for HIV/AIDS. Gilead researchers have developed 11 commercially available HIV medications and are advancing a robust pipeline of next-generation therapeutic options.

Access the reserved area to find out more

Reference

  1. 1. World Health Organization. HIV/AIDS. Available at: https://www.who.int/news-room/facts-in-pictures/detail/hiv-aids
CH-UNB-0498, 05/23